SAB Biotherapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

274.43M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	1.32M	-916.58K	-40.94%
Dec 31, 2023	2.24M	-21.67M	-90.63%
Dec 31, 2022	23.90M	-36.97M	-60.73%
Dec 31, 2021	60.88M	5.64M	10.21%
Dec 31, 2020	55.24M	51.80M	1,504.91%
Dec 31, 2019	3.44M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Foghorn Therapeutics	30.91M
Sol-Gel Technologies	19.39M
LENZ Therapeutics	19.09M
Prelude Therapeutics	12.14M
AC Immune	4.51M
Inhibikase Therapeutics	1.00

Revenue Rankings

SABS News

12 days ago - SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
14 days ago - SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
14 days ago - SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
22 days ago - SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes - GlobeNewsWire
22 days ago - SAB BIO Reports Full Year 2025 Financial Results and Business Highlights - GlobeNewsWire
4 weeks ago - SAB BIO to Participate in Upcoming Investor Conferences - GlobeNewsWire
3 months ago - SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director - GlobeNewsWire
3 months ago - SAB BIO to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire

More News